Friday, July 10, 2026
🇺🇸 FDA

Intelligence · Clinical pipeline

Approved programs Pipeline Programs

ClinicalTrials.gov programs marked approved or launched in registry data.

Programs 1,839
Sponsors 1,771
Drugs 4,798

Quick answer

NovaPharmaNews tracks 1,839 approved programs pharmaceutical pipeline programs from ClinicalTrials.gov. ClinicalTrials.gov programs marked approved or launched in registry data.

Top sponsors

Pipeline programs

Page 24 of 39

  1. Pandemic influenza A/H1N1 vaccine

    Sinovac Research and Development Co.,

    Influenza

    approved mab completed

    1 trial

  2. Pantoprazole

    Takeda

    Gastroesophageal Reflux Disease

    approved small molecule completed

    2 trials

  3. Pantoprazole

    Takeda

    Gastroesophageal Reflux

    approved small molecule completed

    3 trials

  4. Paracetamol

    The University of Hong Kong

    Influenza

    approved small molecule completed

    1 trial

  5. Paracetamol

    United Therapeutics Europe Ltd

    Blood Pressure

    approved small molecule completed

    1 trial

  6. Parecoxib

    The First People's Hospital of Lianyungang

    Emergence Delirium

    approved small molecule active

    1 trial

  7. Parecoxib

    The First People's Hospital of Lianyungang

    Postoperative Pain Management, Pain Threshold, Shoulder Pain, Laparoscopies

    approved small molecule completed

    1 trial

  8. Pariglasgene brecaparvovec

    Lacuna Pharma Pty Ltd

    Glycogen storage disease type Ia (GSDIa)

    approved small molecule active

    1 trial

  9. Peginterferon alfa

    Third Affiliated Hospital, Sun Yat-Sen University

    Chronic Hepatitis B

    approved small molecule active

    1 trial

  10. Peginterferon alfa-2a

    Vera Therapeutics

    Hepatitis B, Chronic

    approved small molecule active

    1 trial

  11. Pegvaliase

    BioMarin Pharmaceutical Australia Pty Ltd

    Phenylketonuria

    approved mab active

    1 trial

  12. Pegyinterferon-alfa-2a

    Chinese University of Hong Kong

    Chronic Hepaititis B

    approved small molecule completed

    1 trial

  13. Pegylated Interferon

    BRIGHT MINDS BIOSCIENCES INC.

    Substance-Related Disorders

    approved small molecule completed

    1 trial

  14. Pegylated liposomal doxorubicin

    The First People's Hospital of Lianyungang

    Breast Cancer

    approved small molecule active

    1 trial

  15. Pembrolizumab

    Merck KGaA, Darmstadt, Germany

    Carcinoma, Non-Small-Cell Lung

    approved small molecule completed

    1 trial

  16. Pentocur pulver till injektionsvätska for Major depressive disorder

    The George Institute

    Major depressive disorder

    approved small molecule active

    1 trial

  17. Perflutren lipid

    United Therapeutics Europe Ltd

    Acute Spinal Cord Injury

    approved small molecule active

    1 trial

  18. Perineural infusion [continuous peripheral nerve block(s)]

    United Therapeutics Europe Ltd

    Phantom Limb Pain

    approved small molecule completed

    1 trial

  19. Pertussis containing vaccine

    United Therapeutics Europe Ltd

    Pregnancy Related

    approved mab active

    1 trial

  20. Pethidine

    Stoke Therapeutics

    Pain Relief in Labour

    approved small molecule completed

    1 trial

  21. Pfizer-BioNTech mRNA COVID-19 vaccine

    BRIGHT MINDS BIOSCIENCES INC.

    COVID -19

    approved small molecule active

    1 trial

  22. Pharmacokinetic based dosage change

    Cardiff Oncology

    Severe Haemophilia A

    approved small molecule completed

    1 trial

  23. Pharmacotherapy

    BRIGHT MINDS BIOSCIENCES INC.

    Smoking

    approved small molecule completed

    1 trial

  24. Pharmacotherapy

    The First People's Hospital of Lianyungang

    Diabetes Mellitus, Type 2

    approved small molecule active

    1 trial

  25. Pharmacotherapy for opioid use disorder

    BRIGHT MINDS BIOSCIENCES INC.

    HIV Infection

    approved small molecule completed

    1 trial

  26. Phenoxybenzamine

    Atrium Therapeutics

    Pheochromocytoma

    approved small molecule completed

    1 trial

  27. Phenylephrine

    United Therapeutics Europe Ltd

    Spinal Anesthesia

    approved small molecule terminated

    1 trial

  28. Pidotimod

    Almirall, S.A.

    Recurrent Respiratory Tract Infections

    approved small molecule completed

    1 trial

  29. Pimavanserin

    Acadia Pharmaceuticals B.V.

    Insomnia Chronic

    approved small molecule terminated

    1 trial

  30. Pimavanserin

    Acadia Pharmaceuticals B.V.

    Parkinson Disease Psychosis

    approved small molecule completed

    1 trial

  31. Pimavanserin

    Acadia Pharmaceuticals B.V.

    Neurodegenerative Diseases

    approved small molecule active

    1 trial

  32. Pioglitazone

    Takeda

    Obesity

    approved small molecule completed

    1 trial

  33. Pioglitazone

    Takeda

    Nonalcoholic Steatohepatitis

    approved small molecule completed

    1 trial

  34. Pioglitazone

    Takeda

    Type II Diabetes Mellitus

    approved small molecule completed

    1 trial

  35. Pioglitazone

    Takeda

    Metabolic Syndrome

    approved small molecule completed

    1 trial

  36. Pioglitazone

    Takeda

    Diabetes Type 2

    approved small molecule completed

    1 trial

  37. Pioglitazone

    Takeda

    Diabetes Mellitus, Type 2

    approved small molecule completed

    2 trials

  38. Pioglitazone

    Takeda

    Diabetes Mellitus

    approved small molecule completed

    9 trials

  39. Pioglitazone

    Takeda

    Bone Metabolism

    approved small molecule completed

    1 trial

  40. Pioglitazone 15mg

    United Therapeutics Europe Ltd

    High Altitude

    approved small molecule completed

    1 trial

  41. Pioglitazone 15mg

    Takeda

    Inflammation

    approved small molecule completed

    1 trial

  42. Pioglitazone and Metformin

    Disc Medicine

    Diabetes Mellitus, Type 2

    approved small molecule completed

    1 trial

  43. Pioglitazone and insulin

    Takeda

    Diabetes Mellitus

    approved small molecule completed

    2 trials

  44. Pioglitazone and metformin

    Takeda

    Diabetes Mellitus

    approved small molecule completed

    5 trials

  45. Pioglitazone then Placebo

    Takeda

    Diabetes

    approved small molecule completed

    1 trial

  46. Pitolisant

    Harmony Biosciences Holdings

    Restless Legs Syndrome

    approved small molecule active

    1 trial

  47. Placebo

    BRIGHT MINDS BIOSCIENCES INC.

    Opioid Dependence

    approved small molecule completed

    1 trial

  48. Placebo

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Gastroesophageal Reflux Disease

    approved other active

    1 trial

Frequently asked questions

How many Approved programs pipeline programs are in the directory?

1,839 published programs match this development stage in our ClinicalTrials.gov index.

What defines this pipeline stage?

Phase and status reflect ClinicalTrials.gov registry fields at last sync. See our clinical trial phases reference for methodology.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.